Funding cuts impact medical research in profound ways, undermining the essential work needed to safeguard patient safety and ethical standards within clinical studies.The recent freeze of over $2 billion in federal research grants has disrupted crucial oversight systems, notably through the SMART IRB program, which plays a vital role in ensuring that medical studies are conducted responsibly.